Ifosfamide with mesna in squamous carcinoma of the cervix: Phase II results in patients with advanced or recurrent disease
Authors:
- T.V. DinhTDT.V. Dinh
- M.G. DohertyMDM.G. Doherty
- 1 November 1991
- journal article
- case report
- Published by Elsevier in Gynecologic Oncology
- Vol. 43 (2) , 123-128
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Phase II study of ifosfamide and mesna in patients with previously-treated carcinoma of the cervixInvestigational New Drugs, 1989
- Phase II Studies of Bleomycin, Ifosfamide and Cis-Platinum in Advanced and Recurrent Cervical CarcinomaActa Oncologica, 1988
- Phase-II Trial with Ifosfamide/Mesna 24 h Intravenously for the Treatment of Advanced Cancer of the Cervix1987
- Ifosfamide — Dosing and Scheduling1987
- Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesna.Journal of Clinical Oncology, 1986
- Prediction of Ifosfamide/Mesna associated encephalopathyEuropean Journal of Cancer and Clinical Oncology, 1986
- Therapeutic effects of single-push or fractionated injections or continuous infusion of oxazaphosphorines (cyclophosphamide, ifosfamide, Asta Z 7557)Cancer, 1984
- Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: A phase ii study of the gynecologic oncology groupCancer, 1981
- Central nervous side effects following ifosfamide monotherapy of advanced renal carcinomaJournal of Cancer Research and Clinical Oncology, 1981
- The integration of chemotherapy into combined modality treatment of solid tumorsCancer Treatment Reviews, 1977